Structure-function study of gemini derivatives with two different side chains at C-20, Gemini-0072 and Gemini-0097

MedChemComm

Volumn 2, Issue 5, 2011, Pages 424-429

  Huet, Tiphaine ^a,c   Maehr, Hubert ^b,d   Lee, Hong Jin ^b   Uskokovic, Milan R ^b   Suh, Nanjoo ^b   Moras, Dino ^a   Rochel, Natacha ^a  

^a UNIVERSITÉ DE STRASBOURG   (France)

^b RUTGERS UNIVERSITY   (United States)

^c UNIVERSITY OF GENEVA   (Switzerland)

^d Chung Ang University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

CALCITRIOL DERIVATIVE; GEMINI 0072; GEMINI 0097; STEROID RECEPTOR COACTIVATOR 1; UNCLASSIFIED DRUG; VITAMIN D RECEPTOR;

ARTICLE; BINDING AFFINITY; BIOLOGICAL ACTIVITY; CHEMICAL MODIFICATION; CHEMICAL STRUCTURE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CRYSTAL STRUCTURE; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; HYPERCALCEMIA; IC 50; PRIORITY JOURNAL; PROTEIN STABILITY; PROTEIN STRUCTURE; STRUCTURE ACTIVITY RELATION; TRANSCRIPTION INITIATION;

EID: 79959569995     PISSN: 20402503     EISSN: 20402511     Source Type: Journal    
DOI: 10.1039/c1md00059d     Document Type: Article

References (25)

1. M. J. Campbell and L. Adorini, The vitamin D receptor as a therapeutic target, Expert Opin. Ther. Targets, 2006, 10, 735-748. (Pubitemid 44479981)
2. S. Christakos, P. Dhawan, B. Benn, A. Porta, M. Hediger, G. T. Oh, E. Jeung, Y. Zhong, D. Ajibade and K. Dhawan, et al. Vitamin D: molecular mechanism of action, Ann. N. Y. Acad. Sci., 2007, 1116, 340-348. (Pubitemid 350274347)
3. G. Eelen, C. Gysemans, L. Verlinden, E. Vanoirbeek, P. De Clercq, D. Van Haver, C. Mathieu, R. Bouillon and A. Verstuyf, Mechanism and potential of the growth-inhibitory actions of vitamin D and ana-logs, Curr. Med. Chem., 2007, 14, 1893-1910. (Pubitemid 47163407)
4. S. Nagpal, S. Na and R. Rathnachalam, Noncalcemic actions of vitamin D receptor ligands, Endocr. Rev., 2005, 26, 662-687. (Pubitemid 41127276)
5. A.W. Norman, P. S. Manchand, M. R. Uskokovic, W. H. Okamura, J. A. Takeuchi, J. E. Bishop, J. I. Hisatake, H. P. Koeffler and S. Peleg, Characterization of a novel analogue of 1alpha,25(OH)(2)-vitamin D(3) with two side chains: interaction with its nuclear receptor and cellular actions, J. Med. Chem., 2000, 43, 2719-2730.
6. Y. Bury, M. Herdick, M. R. Uskokovic and C. Carlberg, Gene regulatory potential of 1alpha,25-dihydroxyvitamin D(3) analogues with two side chains, J. Cell. Biochem., 2001, 81(S36), 179-190.
7. H. Maehr, M. R. Uskokovic, G. S. Reddy and L. Adorini, Calcitriol derivatives with two different side chains at C-20. 24-hydroxy derivatives as metabolic products and molecular probes for VDR exploration, J. Steroid Biochem. Mol. Biol., 2004, 89-90, 35-38. (Pubitemid 38844256)
8. H. Maehr, M. R. Uskokovic, L. Adorini and G. S. Reddy, Calcitriol derivatives with two different side chains at C-20. II. Diastereoselective syntheses of the metabolically produced 24(R)-hydroxygemini, J. Med. Chem., 2004, 47, 6476-6484.
9. H. Maehr, H. J. Lee, B. Perry, N. Suh and M. R. Uskokovic, Calcitriol derivatives with two different side chains at C-20. V. Potent inhibitors of mammary carcinogenesis and inducers of leukemia differentiation, J. Med. Chem., 2009, 52, 5505-5519.
10. M. Inaba, S. Okuno, Y. Nishizawa, Y. Imanishi, T. Katsumata, I. Sugata and H. Morii, Effect of substituting fluorine for hydrogen at C-26 and C-27 on the side chain of 1,25-dihydroxyvitamin D3, Biochem. Pharmacol., 1993, 45, 2331-2336. (Pubitemid 23171097)
11. C. S. Spina, L. Ton, M. Yao, H. Maehr, M. M. Wolfe, M. Uskokovic, L. Adorini and M. F. Holick, Selective vitamin D receptor modulators and their effects on colorectal tumor growth, J. Steroid Biochem. Mol. Biol., 2007, 103, 757-762.
12. H. Maehr, M. Uskokovic, L. Adorini, G. Penna, R. Mariani, P. Panina, N. Passini, E. Bono, S. Perego and M. Biffi, et al. Calcitriol derivatives with two different side chains at C-20. III. An epimeric pair of the gemini family with unprecedented antiproliferative effects on tumor cells and renin mRNA expression inhibition, J. Steroid Biochem. Mol. Biol., 2007, 103, 277-281. (Pubitemid 46401301)
13. H. J. Lee, S. Paul, N. Atalla, P. E. Thomas, X. Lin, I. Yang, B. Buckley, G. Lu, X. Zheng and Y. Lou, et al. Gemini vitamin D analogues inhibit estrogen receptor-positive and estrogen receptor-negative mammary tumorigenesis without hypercalcemic toxicity, Cancer Prev. Res., 2008, 1, 476-484.
14. H. J. Lee, J. Y. So, A. Decastro, A. Smolarek, S. Paul, H. Maehr, M. Uskokovic and N. Suh, Gemini vitamin D analog suppresses ErbB2-positive mammary tumor growth via inhibition of ErbB2/AKT/ERK signaling, J. Steroid Biochem. Mol. Biol., 2010, 121, 408-412.
15. N. Rochel, J. M. Wurtz, A. Mitschler, B. Klaholz and D. Moras, The crystal structure of the nuclear receptor for vitamin D bound to its natural ligand, Mol. Cell, 2000, 5, 173-179. (Pubitemid 30105446)
16. N. Rochel and D. Moras, Ligand binding domain of vitamin D receptors, Curr. Top. Med. Chem., 2006, 6, 1229-1241. (Pubitemid 44110912)
17. F. Ciesielski, N. Rochel and D. Moras, Adaptability of the Vitamin D nuclear receptor to the synthetic ligand Gemini: remodelling the LBP with one side chain rotation, J. Steroid Biochem. Mol. Biol., 2007, 103, 235-242. (Pubitemid 46401297)
18. R. Bouillon, A. Verstuyf, J. Zhao, B. K. Tan and H. Van Baelen, Nonhypercalcemic vitamin D analogs: interactions with the vitamin D-binding protein, Horm. Res., 1996, 45, 117-121. (Pubitemid 26079694)
19. M. A. Arai, K. Takeyama, S. Ito, S. Kato, T. C. Chen and A. Kittaka, High-throughput system for analyzing ligand-induced cofactor recruitment by vitamin D receptor, Bioconjugate Chem., 2007, 18, 614-620. (Pubitemid 47010778)
20. G. Eelen, N. Valle, Y. Sato, N. Rochel, L. Verlinden, P. De Clercq, D. Moras, R. Bouillon, A. Muñoz and A. Verstuyf, Superagonistic fluorinated vitamin D3 analogs stabilize helix 12 of the vitamin D receptor, Chem. Biol., 2008, 15, 1029-1034.
21. P. Antony, R. Sigüeiro, T. Huet, Y. Sato, N. Ramalanjaona, L. C. Rodrigues, A. Mouriño, D. Moras and N. Rochel, Structure-function relationships and crystal structures of the vitamin D receptor bound 2 alpha-methyl-(20S,23S)- and 2 alpha-methyl-(20S,23R)-epoxymethano-1 alpha,25-dihydroxyvitamin D3, J. Med. Chem., 2010, 53, 1159-1171.
22. F. R. Miller, H. D. Soule, L. Tait, R. J. Pauley, S. R. Wolman, P. J. Dawson and G. H. Heppner, Xenograft model of progressive human proliferative breast disease, J. Natl. Cancer Inst., 1993, 85, 1725-1732. (Pubitemid 23320842)
23. F. R. Miller, S. J. Santner, L. Tait and P. J. Dawson, MCF10DCIS.com xenograft model of human comedo ductal carcinoma in situ, J. Natl. Cancer Inst., 2000, 92, 1185a-1186.
24. L. B. Strickland, P. J. Dawson, S. J. Santner and F. R. Miller, Progression of premalignant MCF10AT generates heterogeneous malignant variants with characteristic histologic types and immunohistochemical markers, Breast Cancer Res. Treat., 2000, 64, 235-240. (Pubitemid 32055831)
25. S. J. Santner, P. J. Dawson, L. Tait, H. D. Soule, J. Eliason, A. N. Mohamed, S. R. Wolman, G. H. Heppner and F. R. Miller, Malignant MCF10CA1 cell lines derived from premalignant human breast epithelial MCF10AT cells, Breast Cancer Res. Treat., 2001, 65, 101-110. (Pubitemid 32193613)